Salute e Benessere

Crossject to report first-half 2024 financial results and host webcast on…

Dijon, France, 17 September, 2024 - Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company developing medicines for emergency situations harnessing its award-winning needle-free auto-injector ZENEO®,will report its financial results for the six months ended June 30, 2024, as scheduled on Monday, September 23. In addition, at 18:00 CET that day, CEO Patrick Alexandre will provide a commentary on the company's strategic priorities during a webcast and be available for...

Human Microbiome Market to Hit USD 4,206 Million by 2030 with 31.5% CAGR |…

Browse in-depth TOC on "Human Microbiome Market"250 - Tables50 - Figures300 - Pages Browse in-depth TOC on "Human Microbiome Market" 250 - Tables 50 - Figures 300 - Pages Drivers of Growth The surge in the human microbiome market is largely driven by collaborative research efforts between the microbiome industry and academia, as well as the rise of start-ups and SMEs venturing into the microbiome sector. These smaller entities are attracting major investments thanks to…

Healthcare Staffing Market is expected to generate a revenue of USD 89.12…

The healthcare staffing industry is undergoing transformative changes, with increasing reliance on temporary, travel, and per-diem staffing to meet the ever-growing demand for qualified healthcare workers. Our report delves into key trends, including technological advancements, regulatory shifts, and the evolving landscape of workforce solutions. The healthcare staffing industry is undergoing transformative changes, with increasing reliance on temporary, travel, and per-diem staffing to meet...

Pharmaceutical Drug Delivery Market to Hit USD 2,546 Billion by 2029 |…

Browse in-depth TOC on "Pharmaceutical Drug Delivery Market"907 - Tables63 - Figures718 - Pages Browse in-depth TOC on "Pharmaceutical Drug Delivery Market" 907 - Tables 63 - Figures 718 - Pages Injectable Drug Delivery Sector Leading the Market Injectable drug delivery holds the largest market share among administration routes, primarily due to its effectiveness in managing chronic diseases. Injectables offer advantages over oral medications by improving patient adherence...

CSL Joins Accumulus Synergy to Drive Industry Change

Following the launch of Accumulus Synergy's innovative cloud-based information exchange platform, CSL joins the nonprofit industry association "We are honored to welcome CSL to our member community,” commented Frank Nogueira, Accumulus Chief Executive Officer. “A membership with Accumulus is an investment in the ecosystem. We closely engage with national regulatory agencies (NRAs), trade associations, life sciences organizations, and non-governmental organizations (NGOs) within the…

Zoetis to Introduce First Cartridge-Based AI-Powered Haematology Analyser

Abhay Nayak, President of Global Diagnostics at Zoetis said: "This latest innovation further strengthens our haematology story, particularly when partnered with Vetscan Imagyst® AI Blood Smear – reinforcing the existing capabilities of Zoetis' Virtual Laboratory portfolio to provide a comprehensive and connected platform." Abhay Nayak, President of Global Diagnostics at Zoetis said: "This latest innovation further strengthens our haematology story, particularly when partnered with…

Independent Expert Assessment Validates RenovaroCube's Potential as a…

Assessment by specialist AI team from “PersonalAIze” Highlights the Strength, Potential, and Visionary Talent Behind the Innovative Software as a Service (SaaS) Platform - PersonalAIze, a cutting-edge company in AI and machine learning applications for healthcare, has conducted a comprehensive evaluation of RenovaroCube's advanced AI platform. This effort is spearheaded by PersonalAIze CEOs and AI experts, Mark Hoogendoorn and Sandjai Bhulai, who bring their extensive expertise to assess...

Zoetis to Debut AI-Powered Haematology Technology at London Vet Show

Abhay Nayak, President of Global Diagnostics at Zoetis, said: "This latest innovation further strengthens our haematology story, particularly when partnered with Vetscan Imagyst® AI Blood Smear – reinforcing the existing capabilities of Zoetis' Virtual Laboratory portfolio to provide a comprehensive and connected platform." Abhay Nayak, President of Global Diagnostics at Zoetis, said: "This latest innovation further strengthens our haematology story, particularly when partnered…

Respiree teams up with Roche Diagnostics in APAC to introduce a new simplified…

By the first quarter of 2025, Respiree will team up with Roche to launch pilot programs across APAC that offer a simplified approach to patient monitoring by combining Roche's cobas® pulse system with Respiree's vital sign monitoring. The solution is also expected in future to integrate machine learning models that predict clinical deterioration using historical data with risk scores at the bedside. By the first quarter of 2025,Respireewill team up with Roche to launch pilot programs...

Rob Bazemore Appointed to the Board of Directors of Akari Therapeutics

BOSTON and LONDON, Sept.17, 2024(GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an innovative biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, announces the appointment of Rob Bazemore, experienced life sciences leader, to the Akari Board of Directors effective September 17, 2024. “I am very honored to have the opportunity to work with this distinguished board of directors to advance the portfolio opportunities,” said Mr. Bazemore...

ClariMed Inc. Expands Strategy & Advisory Services in Europe with New Director…

"I'm thrilled to join ClariMed at this exciting time. The company's vision aligns perfectly with my passion for advancing healthcare through human-centered design," Collinson said. "I look forward to leveraging my experience to help our clients navigate the complex regulatory landscape while driving user-centered innovation in the MedTech industry." "I'm thrilled to join ClariMed at this exciting time. The company's vision aligns perfectly with my passion for advancing…

AC Immune Receives Second Milestone Payment Following Progress in Phase 2b…

AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer's DiseasePrescreening rate of Phase 2b ReTain trial triggers clinical development milestone payment in SeptemberPotentially registrational trial is targeting enrollment of approximately 500 participants with pre-symptomatic ADFDA Fast Track designation granted in July for ACI-35.030 (now “JNJ-2056”) for AD Lausanne, Switzerland, September 17, 2024– AC...

BioNTech to Host AI Day as an Edition of its Innovation Series on October 1…

MAINZ, Germany, September 17, 2024 (GLOBE NEWSWIRE)-- BioNTech SE (Nasdaq: BNTX, “BioNTech”), alongside its artificial intelligence (“AI”) company InstaDeep Ltd. (“InstaDeep”), will host an AI Day, an edition of BioNTech's “Innovation Series”, at 09:00 a.m. EDT (3:00 p.m. CEST) on Tuesday, October 1 st, 2024 in London, United Kingdom. The event will provide an overview of BioNTech's and InstaDeep's AI strategy and capabilities, and the application of AI in BioNTech's pipeline and...

Cevira (APL-1702): Photocure Partner Asieris Unveils Efficacy Data of…

Read Asieris' full media release here: https://asieris.com/asieris-unveils-results-for-the-first-time-at-2024-pdtpd-conference-the-efficacy-data-of-non-surgical-treatment-of-cervical-hsil-with-apl-1702-in-reducing-the-histological-grade-of-cervical-preca/ Read Asieris' full media release here:...

Ureteral Access Sheath Market to Reach $2.2 Billion, Globally, by 2033 at 5.5%…

Prime determinants of growth Prime determinants of growth The global ureteral access sheath market is witnessing notable growth due to surge in cases of kidney stones. Kidney stones, or renal calculi, are crystalline mineral deposits that form within the kidneys or urinary tract, posing significant health risks and causing debilitating pain. This surge in prevalence is attributed to various factors, including dietary habits, sedentary lifestyles, dehydration, and metabolic disorders...

RESOURCE-SAVING INNOVATION: MAMMUT LOOPINSULATION

From concept to innovation From concept to innovation The development of Loopinsulation began after an analysis of Mammut's carbon footprint in 2018, which revealed that 13% of the company's CO 2emissions came from rope manufacturing. In response, Mammut conducted extensive research on repurposing...

Monument Therapeutics Announces Grant of UK Patent for Neuroinflammation…

"The granting of this patent represents a significant achievement in our research and development efforts," said Jenny Barnett, Chief Executive Officer of Monument Therapeutics. "MT1980's innovative approach to targeting neuroinflammation positions us at the cutting edge of therapeutic advancement in psychiatry and neurology. We believe this compound has the potential to address significant unmet medical needs and our team is excited to advance MT1980 through the next stages of…

Safe Life completes acquisition of Medisol in Europe

Medisol, headquartered in the Netherlands, is one of the premier European distributors of AEDs with substantial expertise in eCommerce and operations across 30 European countries. This acquisition strategically complements Safe Life's existing portfolio, positioning us to effectively serve markets throughout North America and all of Europe. Medisol, headquartered inthe Netherlands, is one of the premier European distributors of AEDs with substantial expertise in eCommerce and operations...

MinervaX and Wacker Biotech Announce Manufacturing Collaboration for…

MinervaX's lead vaccine candidate, is a novel protein-only vaccine, based on fusions of highly immunogenic and proactive protein domains from selected surface proteins of GBS. The company is strongly committed and dedicated to advancing its novel vaccine and has successfully completed two Phase II clinical trials of its maternal vaccine against GBS and is in preparation to commence Phase III clinical trials in this indication. Data from MinervaX's GBS vaccine is very positive, demonstrating an…

Pampers is partnering with Olly Murs to help make Scratchy Bottom in Dorset the…

Pampers Premium Protection New Baby nappies (sizes 0-3) and Pampers Premium Protection nappies (sizes 4-6) feature an innovative DermaComfort Layer that instantly pulls wetness and mess away from the skin and locks it securely inside the nappy, so babies' delicate skin remains dry and protected from irritants. The ultra-soft materials help the skin to breathe and provide comfort and the Stop & Protect pocket helps to prevent leaks from escaping at the back. The nappies have also approved by…

IMU Biosciences expands leadership team with appointment of industry experts Dr…

IMU Biosciences expands leadership team with appointment of industry experts Dr. John Baker as Chief Executive Officer and Dr. Jason Brown as Chief Business OfficerLondon, UK, 17 September 2024– IMU Biosciences (or “the Company”), a biotechnology company pioneering systems-level immune profiling with AI to drive breakthroughs in precision medicine, today announces an expansion of its leadership team to support the next phase of the Company's growth. Dr. John Baker has been appointed...

EssilorLuxottica and Meta Announce Long Term Partnership, Shaping the Future of…

EssilorLuxottica and Meta Announce Long Term Partnership, Shaping the Future of the Smart Eyewear CategoryBuilding on the success of Ray-Ban Meta glasses, the two pioneering companiesaim to write history of wearables together Paris, France (17 September 2024)– EssilorLuxottica announced today that it has extended its partnership with Meta Platforms by entering into a new long term agreement, under which the parties will collaborate into the next decade to develop...

Véronique Pomi-Schneiter stands down as BioSenic's Deputy CEO

PRIVILEGED INFORMATION Mont-Saint-Guibert, Belgium, September 17, 2024 7.00pm CEST –BioSenic(Euronext Brussels and Paris: BIOS), the clinical stage company specializing in serious autoimmune and inflammatory diseases, today announces that Véronique Pomi-Schneiter resignes for personal reasons as Deputy CEO of BioSenic. Véronique Pomi-Schneiter will fully assist in the transition process and continue to serve as non-executive member of the board of directors of BioSenic, as well as...

Gates Foundation Report Calls for Targeted Global Health Spending to Save…

The Goalkeepers report, "A Race to Nourish a Warming World," projects that without immediate global action, climate change will condemn an additional 40 million children to stunting and 28 million more to wasting between 2024 and 2050. Scaling up solutions now can avoid this outcome, while also building resilience to climate change and spurring much-needed economic growth. The Goalkeepers report, "A Race to Nourish a Warming World," projects that without immediate global…

Altri Comunicati